Abstract:Shikimic acid (SA) is an intermediate of the SA pathway that is present in bacteria and plants. SA has gained great interest because it is a precursor in the synthesis of the drug oseltamivir phosphate (OSF), an efficient inhibitor of the neuraminidase enzyme of diverse seasonal influenza viruses, the avian influenza virus H5N1, and the human influenza virus H1N1. For the purposes of OSF production, SA is extracted from the pods of Chinese star anise plants (Illicium spp.), yielding up to 17% of SA (dry basis content). The high demand for OSF necessary to manage a major influenza outbreak is not adequately met by industrial production using SA from plants sources. As the SA pathway is present in the model bacteria Escherichia coli, several "intuitive" metabolically engineered strains have been applied for its successful overproduction by biotechnological processes, resulting in strains producing up to 71 g/L of SA, with high conversion yields of up to 0.42 (mol SA/mol Glc), in both batch and fed-batch cultures using complex fermentation broths, including glucose as a carbon source and yeast extract. Global transcriptomic analyses have been performed in SA-producing strains, resulting in the identification of possible key target genes for the design of a rational strain improvement strategy. Because possible target genes are involved in the transport, catabolism, and interconversion of different carbon sources and metabolic intermediates outside the central carbon metabolism and SA pathways, as genes involved in diverse cellular stress responses, the development of rational cellular strain improvement strategies based on omics data constitutes a challenging task to improve SA production in currently overproducing engineered strains. In this review, we discuss the main metabolic engineering strategies that have been applied for the development of efficient SA-producing strains, as the perspective of omics analysis has focused on further strain improvement for the production of this valuable aromatic intermediate.

Metabolic Engineering for Microbial Production of Shikimic Acid in Escherichia coli

Metabolic Engineering of Shikimic Acid Biosynthesis Pathway for the Production of Shikimic Acid and Its Branched Products in Microorganisms: Advances and Prospects

Construction of shikimic acid-producing engineered Escherichia coli strains based on ptsHIcrr mutants

Metabolic engineering strategies for enhanced shikimate biosynthesis: current scenario and future developments

Multiple Metabolic Engineering Strategies to Improve Shikimate Titer in Escherichia coli

Shikimic Acid Production in Escherichia coli: From Classical Metabolic Engineering Strategies to Omics Applied to Improve Its Production

Systems engineering of Escherichia coli for high-level shikimate production

Metabolic Engineering of Shikimic Acid-Producing Corynebacterium glutamicum From Glucose and Cellobiose Retaining Its Phosphotransferase System Function and Pyruvate Kinase Activities

Artificial cell factory design for shikimate production in Escherichia coli

Expanding horizons of shikimic acid. Recent progresses in production and its endless frontiers in application and market trends

Metabolic Engineering of Escherichia coli for Bioproduction of (R)-3-Hydroxybutyric Acid through a Three-Pronged Approach

Systematically Engineering Escherichia Coli for Enhanced Shikimate Biosynthesis Co‐utilizing Glycerol and Glucose

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Cell Factory Design and Culture Process Optimization for Dehydroshikimate Biosynthesis in Escherichia coli

Metabolic Engineering of Escherichia coli for High-Level Production of l-Phenylalanine

Metabolic Engineering of Escherichia coli for the Biosynthesis of 3-Phenylpropionic Acid and 3-Phenylpropyl Acetate

Metabolic network rewiring and temperature-dependent regulation for enhanced 3-dehydroshikimate production in Escherichia coli

[Metabolic engineering of Escherichia coli for production of malonic acid].

Metabolic engineering of Corynebacterium glutamicum for producing branched chain amino acids

The metabolic engineering of Escherichia coli for the high-yield production of hypoxanthine

Metabolic engineering of Escherichia coli for biotechnological production of high-value organic acids and alcohols